SCHEMBL9515738

SCHEMBL9515738

O=C(NS(=O)(=O)CC(O)c1ccc(Cl)cc1)c1ccc(COCc2ccccc2)nc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P4HTM Q9NXG6 2/20 0.43
BCL2L1 Q07817 3/20 0.41
MCL1 Q07820 3/20 0.41
NPC1 O15118 3/20 0.40
RAB9A P51151 3/20 0.40
EGFR P00533 1/20 0.38
SCN5A Q14524 1/20 0.37
SCN9A Q15858 1/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
L3MBTL1 Q9Y468 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.35
HDAC6 Q9UBN7 1/20 0.35
CXCR2 P25025 1/20 0.35
TP53 P04637 1/20 0.35
KDM4E B2RXH2 1/20 0.35
ALDH1A1 P00352 1/20 0.35
HPGD P15428 1/20 0.35
HTT P42858 1/20 0.35
SLC6A9 P48067 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9519638 0.92 BCL2L1 (0.42) P4HTMBCL2L1MCL1NPC1RAB9A
SCHEMBL9516093 0.88 HSD11B1 (0.43) P4HTMBCL2L1MCL1SCN5ASCN9A
SCHEMBL9517939 0.87 EGFR (0.40) P4HTMNPC1RAB9AEGFRSCN5A
SCHEMBL9517265 0.84 EGFR (0.41) P4HTMEGFRSCN5ASCN9AL3MBTL1
SCHEMBL9516977 0.83 EGFR (0.44) P4HTMNPC1RAB9AEGFRMEN1
SCHEMBL9517170 0.82 HDAC1 (0.39) P4HTMBCL2L1MCL1HDAC6SLC6A9
SCHEMBL9515729 0.82 BCL2L1 (0.40) P4HTMBCL2L1MCL1NPC1RAB9A
SCHEMBL9516994 0.79 SCN9A (0.38) P4HTMEGFRSCN5ASCN9ASMN1; SMN2
SCHEMBL9517911 0.78 CXCR1 (0.37) P4HTMMEN1KMT2AHDAC6CXCR2
SCHEMBL9566848 0.78 P4HTM (0.55) P4HTMNPC1RAB9AMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0567997-A1 4- or 5-(sulf)imido- and (sulfon)amidopyridines and their pyridine-N-oxides, process for their preparation and their use as pharmaceutical HOECHST AKTIENGESELLSCHAFT (DE) 1993-11-03 EP disclosed